Approval · Notice of Compliance 17543 · 2015
SANDOZ MOMETASONE: Notice of Compliance 17543
Issued December 7, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17543
- Date
- December 7, 2015
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- NASONEX
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SANDOZ MOMETASONE | 02449811 | Marketed |
Medicinal ingredients
- MOMETASONE FUROATE MONOHYDRATE 50 MCG per SPR